Watch and read
Selected conversations, talks, and films on psychedelics and consciousness. Each one carries a considered summary and a full transcript, so you can watch, read, or return to a passage that mattered.
44 videos
Interviews
Michael Pollan on consciousness, attention, and how meditation and psychedelics may soften the ego, not erase it.
Jay Shetty Podcast
Documentaries
A WSJ documentary on the biotech and federal race to turn 5-MeO-DMT, the toad-derived psychedelic, into an approved therapy.
The Wall Street Journal
Talks & Lectures
A neurophysiologist walks through the imaging, cellular, and clinical trial evidence on psilocybin for depression and addiction, including the limits.
TNE with Louisa Nicola
A survey of the archaeological evidence for ancient psychoactive plant use, from Bronze Age Spain to the Eleusinian Mysteries.
Explain In Paint
Aperture's documentary on Spinoza's claim that God and the universe are one, and what that means for the self.
Aperture
Professor Historian surveys five ancient psychoactive substances, from opium to the fungus behind LSD.
Professor Historian
CNBC reports on the FDA's fast-tracked review of psychedelic drugs for PTSD and depression under a new executive order.
CNBC
Pharmacologist Bryan Roth explains the brain receptors behind psychedelics, ibogaine, and salvia in this long interview.
Giant's Shoulder
How Hofmann's accidental 1943 discovery led to CIA experiments and today's psychedelic neuroscience.
Dr Ben Miles
Podcasts
A documentary essay on the neuroscience behind psychedelics, from free energy to the entropic brain hypothesis.
Sam Harris
Michael Pollan talks with Ezra Klein about consciousness, from plant sentience to psychedelics, meditation, and idealism.
The Ezra Klein Show
A mouse study traces how psilocybin changes brain connections, neuron by neuron, using a modified rabies virus.
Chase Hughes
Matthew Johnson (Johns Hopkins) on how psychedelics affect the brain, what the trials show, and why one session can last.
Big Think
A physician explains how psilocybin quiets the brain's default mode network and may ease depression for up to a year.
Tracy Townsend MD
Dr. Matthew Johnson explains psychedelic classes, clinical trial protocols, and the real risks with Andrew Huberman.
Andrew Huberman
PBS NOVA follows patients and researchers exploring psilocybin and MDMA therapy for addiction, depression, and PTSD.
PBS America
Dr. Alok Kanojia walks through what the 5HT2A receptor does, what the trial data actually shows, and why he says most people should probably not do this alone.
HealthyGamerGG
60 Minutes follows veterans using psychedelic retreats, a nerve-block shot, ECT, and AI chatbots to treat PTSD and depression.
60 Minutes
Michael Pollan and four guests describe guided psychedelic experiences for PTSD, OCD, anxiety, and grief on Oprah's podcast.
Oprah
How a Berkeley chemist who credited LSD with his way of thinking arrived at the polymerase chain reaction, and what the story leaves out.
Veritasium
Dr. Matthew Johnson explains why he sees psychedelics as a different approach than SSRIs for depression and addiction.
Freethink
An animated tour through psilocybin's effects on the body and brain, its history, and the science of its therapeutic use.
The Infographics Show
Psychologist James Fadiman reflects on psychedelics, transpersonal psychology, risk, and expanding awareness.
The Institute of Human Anatomy breaks down how LSD moves through the body, binds serotonin receptors, and affects the brain.
Institute of Human Anatomy
Cleo Abram explains why psychedelics banned for decades are now in FDA trials for PTSD and depression, and where real risks remain.
Cleo Abram
Robin Carhart-Harris tells Andrew Huberman how psilocybin, LSD, MDMA, and DMT are being studied to treat depression.
Andrew Huberman explains to Tim Ferriss how psilocybin and MDMA trial data, plus his own guided therapy, changed his views.
Tim Ferriss
One creator's 28-day, self-reported psilocybin microdosing experiment, alongside the survey research it's tested against.
StoneAgeMan
A doctor walks through the clinical trials behind psilocybin for treatment-resistant depression, and what remains unproven.
Doctor Mike Hansen
Sam Harris explains to Andrew Huberman why psychedelics, and MDMA especially, opened his path into meditation.
Huberman Lab Clips
Johns Hopkins psychiatrist Matthew Johnson unpacks the psilocybin heroic dose and what psychedelic therapy research shows.
Johns Hopkins researcher Dr. Matthew Johnson explains the real risks of psychedelics, and what most reduces them.
Dr. Matthew Johnson of Johns Hopkins explains the receptor mechanism and brain changes behind psychedelics in under six minutes.
A NOVA explainer on how psychedelics quiet the brain's default mode network and boost cross-region communication.
NOVA PBS Official
Rick Doblin, Gül Dölen, and Reggie Watts join a World Science Festival panel on psychedelics, the brain, and creativity.
World Science Festival
Michael Pollan answers rapid-fire Twitter questions on LSD, ego death, microdosing, and psychedelic therapy research.
WIRED
Matthew Johnson tells Lex Fridman what a DMT breakthrough dose feels like and why so many users report meeting entities.
Lex Clips
Bloomberg Originals traces the history, brain science, and investment boom behind psychedelic mental health research.
Bloomberg Originals
Four researchers unpack the neuroscience, Amazonian traditions, and emerging clinical evidence behind psychedelics.
Joe Rogan and a guest weigh McKenna's speculative theory that psilocybin sped up early human brain evolution.
JRE Clips
AsapSCIENCE's quick primer on how LSD affects serotonin receptors, brain activity, and what research says about its risks.
AsapSCIENCE
Vox surveys early clinical research on psilocybin and LSD as experimental treatments for anxiety, addiction, and depression.
Vox
AsapSCIENCE breaks down how psilocybin acts on serotonin and brain connectivity to produce hallucinations.
Phil Borges asks whether some psychotic breaks are better understood as spiritual emergencies, drawing on shaman worldwide.
TEDx Talks